Concepedia

Jeffrey McKelvy

JM

5

Publications

294

Citations

5

H-Index

1990

Active since

Affiliations

iTherX (United States)(Current)

Jeffrey McKelvy is an author at iTherX (United States) specializing in drug discovery, hepatitis, and medicine.

Top concepts

Publications per year

1990–2012

5

Publications

5

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

Andrew J. Syder, Haekyung Lee, Mirjam B. Zeisel et al. · Journal of Hepatology · 2010 · 137 citations

, , +7

Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals

Haihong Zhu, Flossie Wong‐Staal, Haekyung Lee et al. · The Journal of Infectious Diseases · 2012 · 66 citations · Full text

Two forms of the rat D<sub>2</sub> dopamine receptor as revealed by the polymerase chain reaction

Donald D. Rao, Jeffrey McKelvy, John W. Kebabian et al. · FEBS Letters · 1990 · 44 citations · Full text

Discovery of ITX 4520: A highly potent orally bioavailable hepatitis C virus entry inhibitor

Gopi Kumar Mittapalli, Fang Zhao, Andrew Jackson et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 24 citations · Full text

, , +8

Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors

Gopi Kumar Mittapalli, Andrew Jackson, Fang Zhao et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 23 citations · Full text

, , +8

Rows per page

1–5 of 5